39 results
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
15 Nov 23
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
8:00am
patient outcomes, reducing healthcare costs and is scalable for broader applications
Evaxion will pursue a partnership-based approach towards … -of-care cancer immunotherapy. This can improve patient outcomes and reduce healthcare costs.
“When I joined Evaxion, I was inspired by the wealth
DRS
EVAX
Evaxion Biotech A/S
22 Oct 20
Draft registration statement
12:00am
cause of community and healthcare facility acquired infections in the US and worldwide. S. aureus has been known to cause symptoms ranging from … difficulty following certain aspects of clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. For example
20-F
2020 FY
EVAX
Evaxion Biotech A/S
7 Apr 21
Annual report (foreign)
4:31pm
of clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. For example, some patients, may not be able to attend … clinical trials. Similarly, if we are unable to successfully recruit and retain patients and principal investigators and site staff who, as healthcare
DRS/A
EVAX
Evaxion Biotech A/S
4 Jan 21
Draft registration statement (amended)
12:00am
factors and covers the diversity of different S. aureus strains.
S. aureus is a leading cause of community and healthcare facility acquired infections … of clinical trial protocols if quarantines impede patient movement or interrupt healthcare services. For example, some patients, may not be able to attend
DRS/A
khh2dl b6
25 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
imw8lwq
16 Dec 20
Draft registration statement (amended)
12:00am
F-1/A
j0dr0sm oh4hgswyr
25 Jan 21
Registration statement (foreign) (amended)
7:01am
424B4
g4o7lq75mz
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1
let476x0adzev
8 Jan 21
Registration statement (foreign)
4:54pm
F-1/A
bhp0rzu3
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
DRS
lzqx 2lkj7
25 Jun 21
Draft registration statement
12:00am
F-1/A
di05ghcqm vuwjsz
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
CORRESP
gvg4f17ha6
29 Oct 21
Correspondence with SEC
12:00am
CORRESP
1vng09vl0wx
2 Feb 21
Correspondence with SEC
12:00am
CORRESP
1toas5d8qn2tc
3 Nov 21
Correspondence with SEC
12:00am
F-1
7mdiscz
12 Jan 24
Registration statement (foreign)
5:17pm
424B4
mhl1p9
5 Nov 21
Prospectus supplement with pricing info
4:47pm